FindTrial
Sign In

Assessment of the risk of obstructive sleep apnea and the quality of sleep among patients with endocrine disorders.

A study to asses the risk of obstructive sleep apnea and quality of sleep among patients with endocrine disorders. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097914
Enrollment
285
Registered
2025-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified Health Condition 2: E669- Obesity, unspecified Health Condition 3: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil Intervention6: Nil: Nil Intervention7: Nil: Nil Intervention8: Nil: Nil Interven

Sponsors

Ningthoujam Leishana Chanu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnoses with Diabetes mellitus, Hypothyroidism and Obesity

Exclusion criteria

Exclusion criteria: Patients who are 1.Critically ill 2.Diagnosed and treated-OSA, sleep disorders 3.Known for psychiatric illness or neurological conditions affecting sleep 4.On medications such as sedatives and hypnotics

Design outcomes

Primary

MeasureTime frame
Assessment of obstructive sleep apnea risk (STOP- Bang Score) and sleep quality (PSQI) Score) among patients with endocrine disorders at a single timepoint.Timepoint: At baseline—

Secondary

MeasureTime frame
1. Correlation between the risk of obstructive sleep apnea (STOP-Bang score) & quality of sleep (PSQI score). 2. Association between OSA risk levels (STOP-Bang categories) & selected demographic variables. 3. Association between sleep quality (PSQI categories) & selected demographic variables.Timepoint: At baseline—

Countries

India

Contacts

Public ContactDr Hezil Reema Barboza

Faculty

hezilreemabarboza@gmail.com9008218663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026